Gene · 3425
Papers1,870
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,870
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enzymatic testing for mucopolysaccharidosis type I in Kuwaiti newborns: a preliminary study toward newborn screening. | Front Pediatr | 2024 | 39077064 | PubTator, text mining | PubMed |
| Primary Ciliary Dyskinesia Associated Disease-Causing Variants in CCDC39 and CCDC40 Cause Axonemal Absence of Inner Dynein Arm Heavy Chains DNAH1, DNAH6, and DNAH7. | Cells | 2024 | 39056782 | PubTator, text mining | PubMed |
| Laronidase-loaded liposomes reach the brain and other hard-to-treat organs after noninvasive nasal administration. | Int J Pharm | 2024 | 38897489 | PubTator, text mining | PubMed |
| Dyslexia in the twenty-first century: a commentary on the IDA definition of dyslexia. | Ann Dyslexia | 2024 | 38877329 | PubTator, text mining | PubMed |
| Targeted proteomics involved in cardiovascular health and heart rate variability in children with overweight/obesity. | Am J Hum Biol | 2024 | 38864311 | PubTator, text mining | PubMed |
| Discovery of allosteric regulators with clinical potential to stabilize alpha-L-iduronidase in mucopolysaccharidosis type I. | PLoS One | 2024 | 38768102 | PubTator, text mining | PubMed |
| Inhibitors of dermatan sulfate epimerase 1 decreased accumulation of glycosaminoglycans in mucopolysaccharidosis type I fibroblasts. | Glycobiology | 2024 | 38760939 | PubTator, text mining | PubMed |
| Engineering Memory T Cells as a platform for Long-Term Enzyme Replacement Therapy in Lysosomal Storage Disorders. | bioRxiv | 2024 | 38712248 | PubTator, text mining | PubMed |
| FLAG/FLAG-Ida Regimen in Secondary and Relapsed/Refractory Acute Myeloid Leukemia-Even in the Era of New Treatment Modalities Still a Significant Player. | J Clin Med | 2024 | 38610607 | PubTator, text mining | PubMed |
| TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage. | Mol Ther | 2024 | 38582963 | PubTator, text mining | PubMed |
| Evaluation, in a highly specialised enzyme laboratory, of a digital microfluidics platform for rapid assessment of lysosomal enzyme activity in dried blood spots. | JIMD Rep | 2024 | 38444576 | PubTator, text mining | PubMed |
| Respiratory distress in SARS-CoV-2 exposed uninfected neonates followed in the COVID Outcomes in Mother-Infant Pairs (COMP) Study. | Nat Commun | 2024 | 38267411 | PubTator, text mining | PubMed |
| Discovering genetic mechanisms underlying the co-occurrence of Parkinson's disease and non-motor traits. | NPJ Parkinsons Dis | 2024 | 38263313 | PubTator, text mining | PubMed |
| Mendelian Randomization Applied to Neurology: Promises and Challenges | Neurology | 2024 | 38261980 | PubTator, text mining | PubMed |
| Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy. | Int J Mol Sci | 2024 | 38256186 | PubTator, text mining | PubMed |
| Novel Associations Between Mid-Pregnancy Cardiovascular Biomarkers and Preeclampsia: An Explorative Nested Case-Control Study. | Reprod Sci | 2024 | 38253981 | PubTator, text mining | PubMed |
| Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases. | Biology (Basel) | 2024 | 38248465 | PubTator, text mining | PubMed |
| Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells. | J Ginseng Res | 2024 | 38223829 | PubTator, text mining | PubMed |
| Mucopolysaccharidosis type I Hurler-Scheie syndrome: a case report. | Ann Med Surg (Lond) | 2024 | 38222696 | PubTator, text mining | PubMed |
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. | J Clin Oncol | 2024 | 38215358 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3425/papers?page=6